サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1556601

ラジオイムノアッセイ（RIA）市場レポート：2030年までの動向、予測、競合分析

Radioimmunoassay (RIA) Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ラジオイムノアッセイ（RIA）市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年08月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ラジオイムノアッセイ（RIA）の動向と予測

世界のラジオイムノアッセイ（RIA：放射免疫測定）市場は、2024年から2030年にかけてCAGR 3.2％の成長が見込まれています。この市場の主な促進要因は、がん罹患率の増加、医療における自動化のニーズの増大、医療研究の進展です。世界のラジオイムノアッセイ（RIA）市場の将来は、病院、製薬、学術、臨床診断検査室の各市場における機会で有望視されています。

ラジオイムノアッセイ（RIA）のセグメント別予測

この調査には、世界のラジオイムノアッセイ（RIA）のタイプ別、用途別、最終用途別、地域別の予測が含まれています。

ラジオイムノアッセイ（RIA）市場の洞察

Lucintelは、試薬・キットが予測期間中に高い成長を遂げると予測しています。

この市場の中で、臨床検査室は、生物学的サンプル中の多種多様な分析物を高スループット、高感度、高特異性で分析できることから、この施設でのラジオイムノアッセイの利用が多いため、最も高い成長が見込まれます。

北米は、有利な償還政策が利用可能であり、強固な医療システムが存在するため、予測期間中最大の地域であり続けると思われます。

よくある質問

Q1.市場の成長予測は：

A1.世界のラジオイムノアッセイ（RIA）市場は、2024年から2030年にかけてCAGR 3.2%で成長すると予想されていますが、その理由は何ですか？

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、がん罹患率の増加、医療における自動化のニーズの高まり、医療研究の進展です。

Q3.市場の主要セグメントは：

A3.ラジオイムノアッセイ（RIA）市場の将来は、病院、製薬、学術、臨床検査室の各市場における機会により有望視されています。

Q4.市場の主要企業は：

A4.ラジオイムノアッセイ（RIA）の主要企業は以下の通りです：

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、試薬・キットは予測期間中に高い成長が見込まれると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.北米は、有利な償還政策が利用可能であり、同地域には強固な医療システムが存在するため、予測期間中も最大地域であり続けます。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のラジオイムノアッセイ（RIA）市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のラジオイムノアッセイ（RIA）市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界のラジオイムノアッセイ（RIA）市場（タイプ別）
    • 試薬・キット
    • 分析装置
  • 世界のラジオイムノアッセイ（RIA）市場（用途別）
    • 臨床診断
    • 研究
  • 最終用途別世界のラジオイムノアッセイ（RIA）市場
    • 病院
    • 製薬
    • 学術
    • 臨床検査室
    • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

  • 世界のラジオイムノアッセイ（RIA）市場：地域別
  • 北米のラジオイムノアッセイ（RIA）市場
  • 欧州のラジオイムノアッセイ（RIA）市場
  • アジア太平洋のラジオイムノアッセイ（RIA）市場
  • その他地域のラジオイムノアッセイ（RIA）市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 世界のラジオイムノアッセイ（RIA）市場における成長機会（タイプ別）
    • 用途別の世界のラジオイムノアッセイ（RIA）市場の成長機会
    • 最終用途別の世界のラジオイムノアッセイ（RIA）市場の成長機会
    • 地域別の世界のラジオイムノアッセイ（RIA）市場の成長機会
  • 世界のラジオイムノアッセイ（RIA）市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界のラジオイムノアッセイ（RIA）市場の能力拡大
    • 世界のラジオイムノアッセイ（RIA）市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore
目次

Radioimmunoassay (RIA) Trends and Forecast

The future of the global radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets. The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Radioimmunoassay (RIA) by Segment

The study includes a forecast for the global radioimmunoassay (RIA) by type, application, end use, and region.

Radioimmunoassay (RIA) Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents & Kits
  • Analyzers

Radioimmunoassay (RIA) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical Diagnostics
  • Research

Radioimmunoassay (RIA) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Pharmaceuticals
  • Academics
  • Clinical Diagnostic Laboratories
  • Others

Radioimmunoassay (RIA) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Radioimmunoassay (RIA) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radioimmunoassay (RIA) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radioimmunoassay (RIA) companies profiled in this report include-

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Radioimmunoassay (RIA) Market Insights

Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Within this market, clinical diagnostic laboratory is expected to witness the highest growth due to substantial usage of radioimmunoassay in this facility given to their ability to analyze a broad variety of analytes in biological samples with high throughput, high sensitivity, and specificity.

North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Features of the Global Radioimmunoassay (RIA) Market

Market Size Estimates: Radioimmunoassay (RIA) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Radioimmunoassay (RIA) market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Radioimmunoassay (RIA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the radioimmunoassay (RIA) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radioimmunoassay (RIA) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for radioimmunoassay (RIA) market?

Answer: The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the radioimmunoassay (RIA) market?

Answer: The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

Q3. What are the major segments for radioimmunoassay (RIA) market?

Answer: The future of the radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets.

Q4. Who are the key radioimmunoassay (RIA) market companies?

Answer: Some of the key radioimmunoassay (RIA) companies are as follows:

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Q5. Which radioimmunoassay (RIA) market segment will be the largest in future?

Answer: Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Q6. In radioimmunoassay (RIA) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the radioimmunoassay (RIA) market by type (reagents & kits and analyzers), application (clinical diagnostics and research), end use (hospitals, pharmaceuticals, academics, clinical diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radioimmunoassay (RIA) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Radioimmunoassay (RIA) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Radioimmunoassay (RIA) Market by Type
    • 3.3.1: Reagents & Kits
    • 3.3.2: Analyzers
  • 3.4: Global Radioimmunoassay (RIA) Market by Application
    • 3.4.1: Clinical Diagnostics
    • 3.4.2: Research
  • 3.5: Global Radioimmunoassay (RIA) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Pharmaceuticals
    • 3.5.3: Academics
    • 3.5.4: Clinical Diagnostic Laboratories
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Radioimmunoassay (RIA) Market by Region
  • 4.2: North American Radioimmunoassay (RIA) Market
    • 4.2.1: North American Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.2.2: North American Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.3: European Radioimmunoassay (RIA) Market
    • 4.3.1: European Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.3.2: European Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.4: APAC Radioimmunoassay (RIA) Market
    • 4.4.1: APAC Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.4.2: APAC Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.5: ROW Radioimmunoassay (RIA) Market
    • 4.5.1: ROW Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.5.2: ROW Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Type
    • 6.1.2: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Application
    • 6.1.3: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Region
  • 6.2: Emerging Trends in the Global Radioimmunoassay (RIA) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Radioimmunoassay (RIA) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radioimmunoassay (RIA) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: DiaSource ImmunoAssays
  • 7.2: Beckman Coulter
  • 7.3: IBL International
  • 7.4: PerkinElmer
  • 7.5: DRG International
  • 7.6: MP Biomedicals
  • 7.7: Cisbio
  • 7.8: Euro Diagnostica
  • 7.9: DiaSorin
  • 7.10: EMD Millipore